At the Bedside: CTLA-4- and PD-1-blocking antibodies in cancer immunotherapy
Author:
Publisher
Wiley
Subject
Cell Biology,Immunology,Immunology and Allergy
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1189/jlb.1212631/fullpdf
Reference116 articles.
1. Activation rules: the two-signal theories of immune activation;Baxter;Nat. Rev. Immunol.,2002
2. Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo;Jenkins;J. Exp. Med.,1987
3. A new analysis of allogeneic interactions;Lafferty;Aust. J. Exp. Biol. Med. Sci.,1975
4. A theory of self-nonself discrimination;Bretscher;Science,1970
5. The three Es of cancer immunoediting;Dunn;Annu. Rev. Immunol.,2004
Cited by 289 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Janus kinase inhibitor overcomes resistance to immune checkpoint inhibitor treatment in peritoneal dissemination of gastric cancer in C57BL/6 J mice;Gastric Cancer;2024-05-28
2. The use of PD-1 functional knockout rats to study idiosyncratic adverse reactions to nevirapine;Toxicological Sciences;2024-05-15
3. Immune-related dermatological adverse events of antitumor immunotherapy with PD-1, PD-L1, CTLA-4 inhibitors;Russian Journal of Skin and Venereal Diseases;2024-05-14
4. The role of tissue-resident memory T cells as mediators for response and toxicity in immunotherapy-treated melanoma—two sides of the same coin?;Frontiers in Immunology;2024-03-18
5. MicroRNAs as regulators of immune checkpoints in cancer immunotherapy: targeting PD-1/PD-L1 and CTLA-4 pathways;Cancer Cell International;2024-03-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3